FDA Advisory Committee Unanimously Recommends Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY) HPV Test as Primary Screening Tool for Detection of Women at High Risk for Cervical Cancer. Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY) shares after opening at $37.49 moved to $37.69 on last trade day and at the end of the day closed at $37.42.
Novartis AG (ADR) (NYSE:NVS) needs to continue investing in research in order to develop new drugs that national health-care systems are willing pay for, a task that gets harder as generic versions of older medicines become available, according to the company’s chairman. Novartis AG (ADR) (NYSE:NVS) shares advanced 0.52% in last trading session and ended the day on $81.73. Novartis AG (ADR) (NYSE:NVS) return on equity ratio is recorded as 13.00% and its return on assets is 7.40%. Novartis AG (ADR) (NYSE:NVS) yearly performance is 19.59%.
Goldcorp Inc. (USA) (NYSE:GG) announces extension of date to acquire common shares of Osisko Mining Corporation. Goldcorp Inc. (USA) (NYSE:GG) shares moved down -0.04% in last trading session and was closed at $26.66, while trading in range of $26.42 – $27.17. Goldcorp Inc. (USA) (NYSE:GG) year to date (YTD) performance is 23.77%.
Drug developer Portola Pharmaceuticals Inc. (NASDAQ:PTLA) added nearly 19 percent more space while extending its lease by five years at HCP Inc.’s Britannia Pointe Grand in South San Francisco. Portola Pharmaceuticals Inc. (NASDAQ:PTLA) weekly performance is 3.12%. On last trading day company shares ended up $28.07. Portola Pharmaceuticals Inc. (NASDAQ:PTLA) distance from 50-day simple moving average (SMA50) is 4.80%. Analysts mean target price for the company is $39.25.
Leave a Reply